NASDAQ:VRAYViewray Stock Price, Forecast & News Adding Choose a watchlist: Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat Daily Premium to add more stocks to your watchlist. Adding Viewray Inc Please log in to your account or sign up in order to add this asset to your watchlist. Log In and Add $2.53 -0.24 (-8.66 %) (As of 08/3/2020 04:00 PM ET) Add Compare Share Today's Range$2.46Now: $2.53▼$2.8050-Day Range$1.95MA: $2.26▼$2.7752-Week Range$1.11Now: $2.53▼$8.51Volume2.19 million shsAverage Volume2.08 million shsMarket Capitalization$372.92 millionP/E RatioN/ADividend YieldN/ABeta0.82 ProfileAnalyst RatingsAdvanced ChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsSocial Media ViewRay, Inc. designs, manufactures and markets MRIdian, the magnetic resonance imaging (MRI)-guided radiation therapy system to image and treat cancer patients simultaneously. The Company offers radiation therapy technology combined with magnetic resonance imaging. MRIdian integrates MRI technology, radiation delivery and the Company's software to locate, target and track the position and shape of soft-tissue tumors while radiation is delivered. MRIdian delivers radiation to the tumor accurately while delivering less radiation to healthy tissue. MRIdian provides real-time imaging that defines the targeted tumor from the surrounding soft tissue and other critical organs during radiation treatment. MRIdian allows physicians to record the level of radiation exposure that the tumor has received and adapt the prescription between fractions as needed.Read More Beat the Market (BTM) Rank™ 3.3 Analyst's Opinion Consensus RatingViewray has received a consensus rating of Buy. The company's average rating score is 2.50, and is based on 6 buy ratings, 3 hold ratings, and 1 sell rating.Price Target Upside/DownsideAccording to analysts' consensus price target of $4.83, Viewray has a potential upside of 91.0% from its current price of $2.53.Amount of Analyst CoverageViewray has only been the subject of 3 research reports in the past 90 days. Previous Next 2.8 Community Rank Outperform VotesViewray has received 275 “outperform” votes. (Add your “outperform” vote.)Underperform VotesViewray has received 218 “underperform” votes. (Add your “underperform” vote.)Community SentimentViewray has received 55.78% “outperform” votes from our community.MarketBeat's community ratings are surveys of what our community members think about Viewray and other stocks. Vote “Outperform” if you believe VRAY will outperform the S&P 500 over the long term. Vote “Underperform” if you believe VRAY will underperform the S&P 500 over the long term. You may vote once every thirty days. Previous Next 0.0 Dividend Strength Dividend YieldViewray does not currently pay a dividend.Dividend GrowthViewray does not have a long track record of dividend growth. Previous Next 1.0 Company Ownership Insider Buying vs. Insider SellingIn the past three months, Viewray insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 3.00% of the stock of Viewray is held by insiders.Percentage Held by Institutions83.62% of the stock of Viewray is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 0.6 Earnings and Valuation Earnings GrowthEarnings for Viewray are expected to grow in the coming year, from ($0.67) to ($0.66) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Viewray is -2.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Viewray is -2.84, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioViewray has a P/B Ratio of 1.72. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next Analyst Opinion: 3.3Community Rank: 2.8Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -Overall Beat the Market Rank™1.54 out of 5 stars Industry, Sector and Symbol Stock Exchange NASDAQ Industry Electromedical equipment Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:VRAY Previous Symbol CUSIPN/A CIK1597313 Webwww.viewray.com Phone440-703-3210Debt Debt-to-Equity Ratio0.27 Current Ratio4.81 Quick Ratio3.87Price-To-Earnings Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/A Sales & Book Value Annual Sales$87.78 million Price / Sales4.25 Cash FlowN/A Price / Cash FlowN/A Book Value$1.47 per share Price / Book1.72Profitability EPS (Most Recent Fiscal Year)($1.18) Net Income$-120,200,000.00 Net Margins-166.74% Return on Equity-63.54% Return on Assets-36.39%Miscellaneous EmployeesN/A Outstanding Shares147,399,000Market Cap$372.92 million Next Earnings Date11/10/2020 (Estimated) OptionableOptionable $2.53 -0.24 (-8.66 %) (As of 08/3/2020 04:00 PM ET) 30 days | 90 days | 365 days | Advanced Chart Receive VRAY News and Ratings via Email Sign-up to receive the latest news and ratings for VRAY and its competitors with MarketBeat's FREE daily newsletter. Viewray (NASDAQ:VRAY) Frequently Asked Questions How has Viewray's stock been impacted by COVID-19 (Coronavirus)? Viewray's stock was trading at $1.69 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, VRAY shares have increased by 49.7% and is now trading at $2.53. View which stocks have been most impacted by Coronavirus. Do Wall Street analysts recommend investors buy shares of Viewray? 10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Viewray in the last year. There are currently 1 sell rating, 3 hold ratings and 6 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Viewray. When is Viewray's next earnings date? Viewray is scheduled to release its next quarterly earnings announcement on Tuesday, November 10th 2020. View our earnings forecast for Viewray. How were Viewray's earnings last quarter? Viewray Inc (NASDAQ:VRAY) posted its quarterly earnings data on Thursday, July, 30th. The company reported ($0.18) EPS for the quarter, missing the Zacks' consensus estimate of ($0.16) by $0.02. The business earned $14.22 million during the quarter, compared to the consensus estimate of $5.81 million. Viewray had a negative net margin of 166.74% and a negative return on equity of 63.54%. View Viewray's earnings history. What price target have analysts set for VRAY? 10 equities research analysts have issued 12 month price objectives for Viewray's stock. Their forecasts range from $2.00 to $8.00. On average, they expect Viewray's share price to reach $4.83 in the next year. This suggests a possible upside of 91.0% from the stock's current price. View analysts' price targets for Viewray. Has Viewray been receiving favorable news coverage? Press coverage about VRAY stock has trended somewhat positive recently, InfoTrie Sentiment reports. InfoTrie ranks the sentiment of media coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of publicly-traded companies on a scale of negative five to five, with scores closest to five being the most favorable. Viewray earned a news sentiment score of 1.8 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an impact on the company's share price in the near term. View the latest news about Viewray. Who are some of Viewray's key competitors? Some companies that are related to Viewray include InMode (INMD), BioLife Solutions (BLFS), Zynex (ZYXI), Natus Medical (NTUS), AxoGen (AXGN), TransMedics Group (TMDX), Semler Scientific (SMLR), Stereotaxis (STXS), Cutera (CUTR), BioSig Technologies (BSGM), Fonar (FONR), Edap Tms (EDAP), electroCore (ECOR), Soleno Therapeutics (SLNO) and CHF Solutions (CHFS). View all competitors. What other stocks do shareholders of Viewray own? Based on aggregate information from My MarketBeat watchlists, some companies that other Viewray investors own include Alibaba Group (BABA), Amarin (AMRN), Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), Crispr Therapeutics (CRSP), Corbus Pharmaceuticals (CRBP), Viking Therapeutics (VKTX), Verastem (VSTM), Anavex Life Sciences (AVXL) and Inovio Pharmaceuticals (INO). When did Viewray IPO? (VRAY) raised $52 million in an initial public offering (IPO) on the week of April 6th 2015. The company issued 4,000,000 shares at a price of $12.00-$14.00 per share. Cowen and Company and Stifel acted as the underwriters for the IPO and BTIG and Brean Capital were co-managers. What is Viewray's stock symbol? Viewray trades on the NASDAQ under the ticker symbol "VRAY." Who are Viewray's major shareholders? Viewray's stock is owned by a variety of retail and institutional investors. Top institutional investors include Candriam Luxembourg S.C.A. (0.62%), Rhenman & Partners Asset Management AB (0.53%), UBS Group AG (0.15%), SG Americas Securities LLC (0.04%), Hodges Capital Management Inc. (0.04%) and Financial Advisory Corp UT ADV (0.03%). Company insiders that own Viewray stock include Fmr Llc, International Ltd Fosun, James F Dempsey, Orbimed Advisors Llc, Scott William Drake and Shahriar Matin. View institutional ownership trends for Viewray. Which institutional investors are selling Viewray stock? VRAY stock was sold by a variety of institutional investors in the last quarter, including Ieq Capital LLC, and Rhenman & Partners Asset Management AB. View insider buying and selling activity for Viewray. Which institutional investors are buying Viewray stock? VRAY stock was bought by a variety of institutional investors in the last quarter, including Candriam Luxembourg S.C.A., UBS Group AG, Hodges Capital Management Inc., SG Americas Securities LLC, ProShare Advisors LLC, and Financial Advisory Corp UT ADV. Company insiders that have bought Viewray stock in the last two years include International Ltd Fosun, Scott William Drake, and Shahriar Matin. View insider buying and selling activity for Viewray. How do I buy shares of Viewray? Shares of VRAY can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. What is Viewray's stock price today? One share of VRAY stock can currently be purchased for approximately $2.53. How big of a company is Viewray? Viewray has a market capitalization of $372.92 million and generates $87.78 million in revenue each year. The company earns $-120,200,000.00 in net income (profit) each year or ($1.18) on an earnings per share basis. What is Viewray's official website? The official website for Viewray is www.viewray.com. How can I contact Viewray? Viewray's mailing address is 2 THERMO FISHER WAY, OAKWOOD VILLAGE OH, 44146. The company can be reached via phone at 440-703-3210 or via email at [email protected] This page was last updated on 8/4/2020 by MarketBeat.com Staff 30 Days of MarketBeat All Access for $1.00 Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your Risk-Free Trial Subscription Here Questions? Get Started with MarketBeat — Read Your Daily NewsletterCheck Out My MarketBeatWatch Our Tutorial VideosAdd a Stock to Your WatchlistSet Up an Instant AlertView a Company's Profile PageView Our Financial CalendarsView Today's Analyst Ratings
